Fax: (615) 342-1745
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium†
A Phase II trial of the Minnie Pearl Cancer Research Network
Version of Record online: 26 APR 2005
Copyright © 2005 American Cancer Society
Volume 103, Issue 11, pages 2298–2303, 1 June 2005
How to Cite
Hainsworth, J. D., Meluch, A. A., Litchy, S., Schnell, F. M., Bearden, J. D., Yost, K. and Greco, F. A. (2005), Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium. Cancer, 103: 2298–2303. doi: 10.1002/cncr.21078
Minnie Pearl Cancer Research Network participating sites included the following: Tennessee Oncology, PLLC (Nashville, TN), Central Georgia Hematology and Oncology (Macon, GA), Upstate Carolina Community Clinical Oncology Program (Spartanburg, SC), Grand Rapids Community Clinical Oncology Program (Grand Rapids, MI), Atlanta Cancer Care (Atlanta, GA), Northwest Georgia Oncology Centers (Marietta, GA), Consultants in Blood Disorders and Cancer (Louisville, KY), Earl A. Chiles Research Institute (Portland, OR), Terrebonne General Medical Center (Houma, LA), The Hematology and Oncology Clinic (Hattiesburg, MS), Thompson Oncology Group (Knoxville, TN), South Texas Hematology and Oncology (San Antonio, TX), Kingsport Hematology and Oncology Associates (Kingsport, TN), Medical Consultants (Milwaukee, WI), and Louisiana Oncology (Lafayette, LA).
- Issue online: 18 MAY 2005
- Version of Record online: 26 APR 2005
- Manuscript Accepted: 2 FEB 2005
- Manuscript Revised: 4 JAN 2005
- Manuscript Received: 1 SEP 2004
- Eli Lilly, Inc.
- Bristol-Myers Squibb
- The Minnie Pearl Foundation
- 1Cancer of the bladder. In: DeVitaVTJr., HellmanS, RosenbergSA, editors. Cancer principles and practice of oncology, 5th edition. Philadelphia: Lippincott-Raven, 1997: 1300–1322., , .